Associated Papers
Prognostic Relevance of Clinical and Tumor Mutational Profile in High-Grade Serous Ovarian Cancer.
Martín-Vallejo J et al.
International Journal of Molecular Sciences, 2025
40806544 (PubMed )
Supplement: ijms-26-07416-s001.zip › ijms-3735564-supplementary.pdf
Clinical relevance of the somatic mutational landscaping in predicting outcome of bladder cancer patients.
Nedjadi T et al.
Scientific Reports, 2025
TP53_PROF: a machine learning model to predict impact of missense mutations in TP53.
Ben-Cohen G et al.
Briefings in Bioinformatics, 2022
35043155 (PubMed )
Supplement: supplementary_table_s1_bbab524.xlsx › S1B._Negative_Set
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Schulze K et al.
Nature Genetics, 2015
25822088 (PubMed )
Supplement: NIHMS62359-supplement-3.pdf
Ethnic differences and functional analysis of MET mutations in lung cancer.
Krishnaswamy S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2009
Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
Zieger K et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2005
16278391 (PubMed )
Supplement: 10780432ccr051130-sup-ccr_11-1-05_zieger.pdf
Select a paper to view details